Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors

Abata Therapeutics Announces First Development Candidate, ABA-101, a Novel Treg Cell Therapy for the Treatment of Progressive Multiple Sclerosis

Magenta Therapeutics Presents Positive MGTA-117 Clinical Data at The American Society Of Hematology (ASH) Annual Meeting and Provides Program Updates

Asher Bio Presents New Preclinical Data at ASH Applying Cis-Targeted Cytokines to Enhance CAR-T Cell Therapies

Abata Therapeutics Appoints Ellen Cahir-McFarland, Ph.D., as Chief Scientific Officer